Disposable Syringes Market Size, Share & Trends Analysis Report By Product (Conventional Syringes, Safety Syringes), By Application (Immunization Injections, Therapeutic Injections), By Region, And Segment Forecasts, 2022 - 2030

New York, May 23, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Disposable Syringes Market Size, Share & Trends Analysis Report By Product, By Application, By Region And Segment Forecasts, 2022 - 2030" - https://www.reportlinker.com/p06277994/?utm_source=GNW Disposable Syringes Market Growth & Trends The global disposable syringes market size is anticipated to reach USD 22.81 billion by 2030, registering a CAGR of 6.12% over the forecast period. The market is expected to expand due to the increasing adoption of safety syringes, technological advancements, increasing demand for vaccines along with growing adoption of self-administration of drugs are supporting the market growth of disposable syringes. The COVID-19 pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment.As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulted in rise in demand for disposable syringes. In January 2020, in the U.S alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. This in turn, positively impacted the market growth and is estimated to continue to be a growth driver. Moving forward, organizations like United Nations Children’s Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future. Disposable Syringes Market Report Highlights • By product, safety syringes accounted for the largest market revenue share of 64.03% in 2021, due to its advantages being easy to use, and eliminating the risk of patient-to-patient transmission of infections • Based on the application, the therapeutic injection segment dominated the market with a market revenue share of 51.19% in 2021, owing to the increasing awareness of blood donation and the high prevalence of diseases such as HIV infection, tuberculosis malaria, and dengue in the developing and underdeveloped countries • The Asia Pacific dominated the disposable syringe market with the highest revenue share of 31.06% in 2021 due to the presence of a huge aging population base along with the prevalence of chronic diseases in the region • The market in the MEA is expected to witness the fastest growth rate at a compound annual growth rate ( CAGR ) of 8.07% over the forecast period. The growth is attributed to the growing geriatric population, an increasing number of surgeries, and rising expenditure on healthcare Read the full report: https://www.reportlinker.com/p06277994/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

Fight back against inflation. This is how Dalio does it.

These rapidly growing stocks are begging to be bought following a more than 30% peak decline in the Nasdaq.

The stock market pulled back from the brink of a bear market as rate-hike expectations eased, at least for now. Here's what it will take to signal a bottom.

The stock market ended its multiweek losing streak, and like a sports team that finally got a win, it’s worth celebrating. It just doesn’t mean the team—or this stock market—is any good. “Stocks finally enjoyed a strong bounce this week,” writes Canaccord Genuity analyst Martin Roberge.

The market is unstable. Your portfolio doesn’t need to be.

Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and the reward potentials – than penny stocks. These equities, priced below $5 per share, typically offer high upside potentials. Even a small gain in share price – just a few cents – quickly translates into a high yield return. Of course, the risk is real, too; not every penny stock is going to show th

These two fintechs are generating strong revenue growth, but have been caught up in the market swoon.

Qualcomm CEO Cristiano Amon weighs in on the outlook for the semiconductor industry and his company's future.

Whether you're looking for household goods at discounted prices or need to buy your grocery items in bulk, Costco is the go-to retailer for millions of shoppers across the U.S. But despite its ability to attract a loyal following, Costco has made a number of changes recently that haven't thrilled customers. In April, the warehouse retailer got rid of its special COVID hours for seniors, and just this month, Costco ended its mortgage program for members. Now, the retailer has a new warning for sh

Financial technology company Upstart Holdings (NASDAQ: UPST) has proven to be one of the most volatile stocks on Wall Street since going public at the end of 2020. Investors were shocked when Upstart's 2022 first-quarter earnings report revealed a surge in loans on the company's balance sheet, a potentially risky situation in an economy that appears to be slowing. Upstart receives a fee for the loans it touches, making it more a technology platform than an actual lender.

Will we have enough to ‘live a simple life’ in retirement? Many other retirees wonder the same thing as you, and may be in similar financial circumstances where they’re able to pay the bills and have money saved in their retirement accounts. Your interest rate is fantastic, you’re capable of making the monthly payment from just your pension and Social Security without tapping into your 401(k) and you have so much of your home already paid off — all wins.

Ulta shares are up after its big Q1 earnings beat, Aurora Cannabis increased its finance deal to $150 million, and Blackberry stock is surging after news of its partnership with Google.

The cannabis company's per-share loss was almost five times as big as analysts had expected. The stock plunged in response.

In this article, we will discuss some of the notable stocks analysts are upgrading today. To take a look at some more stocks that are being upgraded, go to Analysts Are Upgrading These 5 Stocks on Friday. The US market closed in the green for the first time in the last seven weeks as positive […]

As of 12:24 p.m. ET, Aurora shares were still down 38.8%. At the same time, Tilray (NASDAQ: TLRY) shares were down 3.6%, and Hexo (NASDAQ: HEXO) stock was down 5.3%. The plunge in Aurora shares comes as existing shareholders react to a new round of financing that the company said will bring $150 million to the company.

Wood's flagship Ark Innovation ETF has fallen 52% this year as technology companies have tumbled.

Here are three stocks that could easily turn $10,000 into $50,000 by 2030. Teladoc Health (NYSE: TDOC) could deliver a 5x return simply by returning to where its shares traded less than a year ago. Since last summer, the telemedicine stock has plunged close to 80%.

Shares of Chevron (NYSE: CVX) have surged this year. Higher oil prices have been a major catalyst for Chevron this year. Chevron increased its dividend for the 35th straight year in early 2022 and said it would buy back as much as $10 billion of its stock this year.

Aristotle Capital Management, an independent/employee-owned investment management organization, published its “Global Equity Fund” first quarter 2022 investor letter – a copy of which can be downloaded here. For the first quarter of 2022, Aristotle Capital’s Global Equity Composite posted a total U.S. dollar return of -9.19% gross of fees (-9.28% net of fees), compared to […]

Shares of Farfetch Limited (NYSE: FTCH), a luxury fashion e-commerce platform, spiked today after the company reported a better-than-expected loss in the first quarter. Farfetch reported an adjusted loss per share of $0.24 in the first quarter, which was down from a loss of $0.22 per share in the year-ago quarter but ahead of analysts' average estimate of a loss of $0.28 per share. "Our core business remains very strong, in spite of the macro events in China and ceasing operations in Russia, which impacted our performance and outlook," José Neves, Farfetch's founder and CEO, said in a press release.